Trial NCT04512261

View at ClinicalTrials.gov 
Org. Study IDs: IIT2019-21-Basho-TOPAZ

Last trial update was posted on 2022-07-01

MeSH Interventions

Pembrolizumab Trastuzumab Tucatinib

MeSH Conditions

Brain Neoplasms Breast Neoplasms Central Nervous System Diseases Neoplasm Metastasis

Other Conditions

Brain Metastases Breast Cancer CNS Disease HER2-positive Breast Cancer

Stopping Reasons

Study withdrawn due to change in treatment landscape for HER2+ metastatic breast cancer.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID